Lexeo shares gain 5.4% after up to $21.3 million Mantle deal
AI Summary- Lexeo agreed to acquire Mantle Therapeutics and announced three FA research collaborations.
- Up to $21.3 million will fund the transaction, including $8.3 million upfront.
- Lexeo expects the Mantle transaction to close in the third quarter of 2026.